AFIB ABLATION PILOT: Ablation of Atrial Fibrillation by Radiofrequency.

Review: A European multicenter registry, (mainly in France, Italy and Germany), which included 1,410 patients – evidence of real-world – in which ablation performed by radiofrequency had a success rate of 74% (without arrhythmias to 3 months) and a low rate of complications, (2.6%, 0.54% CVA and 0.71% vascular injuries). With patients in whom the procedure was successful, 18% required a second ablation and 51% antiarrhythmic therapy, although the total number of patients in the proportion of patients receiving antiarrhythmic therapy accounted for 32%.


Elena Arbelo
2012-08-27

Original title: AFIB ABLATION PILOT: ESC-EURObservational Research Programme: 1-year follow-up of the Atrial Fibrillation Ablation Conducted by the European Heart Rhythm Association

More articles by this author

JAPAN EQ: Cardiovascular risk after natural disasters.

Natural disasters have been associated with an increase in cardiovascular mortality. In the Miyagi area, near the epicenter of an earthquake and tsunami in...

WOEST: Randomized trial that compared dual therapy versus triple therapy on anticoagulated patients.

A multicenter randomized study, (n = 573), that evaluated the role of aspirin in anticoagulated patients undergoing angioplasty. The primary endpoint was the rate...

CORE 320: Diagnostic performance of coronary angiotomography including evaluation of myocardial perfusion versus isolated anatomical assessment.

Review: The CORE-320 multicenter study compared combined angiotomography assessments: anatomical (coronary) and functional (myocardial perfusion) versus anatomical only. For this study, 381 patients who...

PRAGUE-12: Surgical Atrial Ablation: Follow the one-year results.

Review: Two hundred twenty-four patients in a surgical plan, (coronary artery bypass grafting or valve), were randomized to cardiac surgery alone or associated with...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img
Jornadas Guatemala 2026

Recent Articles

SAPIEN 3 TAVI Durability: Ten-Year Follow-Up in Intermediate-Risk Patients

The durability of transcatheter bioprosthetic valves used in TAVI remains one of the key unanswered questions as indications continue to expand toward patients with...

Aneurysm Sac Regression Predicts Better Clinical Outcomes After EVAR?

Aneurysm sac regression following endovascular abdominal aortic aneurysm repair (EVAR) has been proposed as a marker of favorable remodeling and effective aneurysm exclusion. However,...

Inflammation after TAVI: An Emerging Therapeutic Target?

Conduction disturbances and the need for permanent pacemaker implantation remain common complications following TAVI, with an incidence approaching 15%. Although they have traditionally been...